1. Home
  2. PRVA vs RLAY Comparison

PRVA vs RLAY Comparison

Compare PRVA & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Privia Health Group Inc.

PRVA

Privia Health Group Inc.

HOLD

Current Price

$27.79

Market Cap

3.5B

Sector

Technology

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$18.97

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRVA
RLAY
Founded
2007
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
4.1B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
PRVA
RLAY
Price
$27.79
$18.97
Analyst Decision
Buy
Strong Buy
Analyst Count
12
10
Target Price
$31.17
$19.50
AVG Volume (30 Days)
1.2M
4.2M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
63.64
31.78
EPS
0.02
N/A
Revenue
$2,122,842,000.00
$15,355,000.00
Revenue This Year
$18.19
N/A
Revenue Next Year
$10.72
$324.03
P/E Ratio
$1,396.45
N/A
Revenue Growth
22.26
53.44
52 Week Low
$18.78
$3.03
52 Week High
$28.41
$20.79

Technical Indicators

Market Signals
Indicator
PRVA
RLAY
Relative Strength Index (RSI) 71.33 57.03
Support Level $22.78 $12.10
Resistance Level N/A $20.79
Average True Range (ATR) 0.82 1.29
MACD 0.08 -0.13
Stochastic Oscillator 72.51 41.64

Price Performance

Historical Comparison
PRVA
RLAY

About PRVA Privia Health Group Inc.

Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Share on Social Networks: